Streptococcus pneumoniae serotype 9V

Streptococcus pneumoniae serotype 9V is a subtype of the Gram-positive bacterial species S. pneumoniae distinguished by its unique capsular polysaccharide structure. The capsule is encoded by a specific locus containing genes responsible for biosynthesis and regulation; these include glycosyltransferases, O-acetyltransferases, an N-acetylglucosamine epimerase, glucose dehydrogenase, transporter proteins, and polymerases involved in constructing the repeating unit that defines this serotype’s capsule[1]. Serotype 9V is clinically significant because it causes invasive diseases such as pneumonia and bacteremia. It is included in several pneumococcal vaccines as a purified or conjugated capsular antigen to induce protective immunity against infection with this strain. Clinical isolates often display multidrug resistance due to various genetic mechanisms affecting antibiotic targets or efflux systems; thus monitoring susceptibility patterns remains important for treatment decisions. The presence or absence of anti-serotype-specific antibodies can serve as biomarkers following vaccination with relevant formulations.[1][3][4][5]

Other names

Streptococcus pneumoniae type 9VS. pneumoniae serotype 9VPneumococcal capsular polysaccharide type 9V vaccine (for the antigen)Pneumococcal polysaccharide serotype 9V[5][7]

Induction of protective immunity via generation of antibodies against the capsular polysaccharide antigen, preventing infection by opsonization and phagocytosis enhancement when used in vaccines[5].